Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Mirum Pharmaceuticals
LEI 254900YZKR40F7F27K81

Nom de l'organisation
Mirum Pharmaceuticals, Inc.
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
316 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).

Récompenses

Actualités

08/05/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
28/02/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
11/01/2024 Mirum Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
08/01/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
18/12/2023 Mirum Pharmaceuticals: Other Events
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2024
I q ang
2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
II q ang
III q ang
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    254900YZKR40F7F27K81
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001759425
  • EIN
    83-1281555

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.